InvestorsHub Logo
Followers 92
Posts 28802
Boards Moderated 2
Alias Born 04/19/2013

Re: laraz5 post# 15659

Thursday, 01/18/2018 10:16:10 AM

Thursday, January 18, 2018 10:16:10 AM

Post# of 21373
What evidence is provided that anyone from GHS told shareholders anything? a MB poster said so?? lol

Why did Lisa Johnson tell a shareholders that Prolanta showed signs of anything



Besides, why would it matter when its public information??

Furthermore, we have observed evidence of efficacy in the low dose patients (tumor reduction) treated with Prolanta in our current ovarian cancer trial, in late-stage ovarian cancer patients that seldom respond to any treatment.

ouch!



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.